EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 229 filers reported holding EDITAS MEDICINE INC in Q4 2019. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $505,000 | +45.5% | 17,028 | +11.9% | 0.00% | +50.0% |
| Q3 2019 | $347,000 | -2.0% | 15,223 | +6.1% | 0.00% | -33.3% |
| Q2 2019 | $354,000 | +5.4% | 14,342 | +2.6% | 0.00% | 0.0% |
| Q1 2019 | $336,000 | +45.5% | 13,981 | +38.0% | 0.00% | +50.0% |
| Q4 2018 | $231,000 | -42.1% | 10,134 | -19.4% | 0.00% | -33.3% |
| Q3 2018 | $399,000 | +16.7% | 12,581 | +22.0% | 0.00% | 0.0% |
| Q2 2018 | $342,000 | 0.0% | 10,314 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $342,000 | +280.0% | 10,314 | +252.6% | 0.00% | +200.0% |
| Q4 2017 | $90,000 | +200.0% | 2,925 | +129.4% | 0.00% | – |
| Q3 2017 | $30,000 | +50.0% | 1,275 | +6.2% | 0.00% | – |
| Q2 2017 | $20,000 | -16.7% | 1,200 | +9.1% | 0.00% | – |
| Q1 2017 | $24,000 | +4.3% | 1,100 | -23.1% | 0.00% | – |
| Q4 2016 | $23,000 | +9.5% | 1,430 | -12.3% | 0.00% | – |
| Q3 2016 | $21,000 | +61.5% | 1,630 | +207.5% | 0.00% | – |
| Q2 2016 | $13,000 | – | 530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |